Prostate Metabolism, Cancer Risk and Gut Microbiota
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorTurku University Hospital
About this trial
This is a prospective, single center translational multiple cohort study to investigate the association of gut microbiota and prostate cancer.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form.
Ability and stated willingness to comply with all study procedures and availability for the duration of the study.
Disqualifiers
inability to comply with study procedures or unwillingness to participate in the study.
Trial design
Treatments tested in this trial
- MRI scan and laboratory visit
- Prostate biopsies
- Radical prostatectomy and blood, urine and tissue sampling
- TURP and blood, urine and tissue sampling
- Radical cystoprostatectomy and blood, urine and tissue sampling
Treatment groups
300 Participants
are divided into 4 treatment groupsSponsors and collaborators
Turku University Hospital
Lead sponsor
University of Turku
Collaborator
Source ClinicalTrials.gov